NEW YORK (Reuters Health) – In patients with diffuse cutaneous systemic sclerosis (dcSSc), treatment with rituximab depletes B cells in the peripheral circulation and in skin, with few…
NEW YORK (Reuters Health) – In middle-aged Chinese adults, hyperuricemia is an independent risk factor for all-cause mortality, cardiovascular disease, and ischemic stroke, according to results of prospective…
NEW YORK (Reuters Health) – Educating patients with end-stage renal disease (ESRD) to avoid processed and fast foods prepared with phosphorus-containing additives results in clinically significant improvements in…
[CLIN] – Intravesical chondroitin may relieve interstitial cystitis NEW YORK (Reuters Health) – The results of a small open-label study suggest that intravesical chondroitin sulphate is a safe…
NEW YORK (Reuters Health) – In patients with vestibular schwannomas related to neurofibromatosis type 2 (NF2), gamma knife radiosurgery can achieve good tumor control in about two-thirds of…
NEW YORK (Reuters Health) – Children born by cesarean delivery are at increased risk for developing asthma, particularly if their parents have allergies, according to a report in…
NEW YORK (Reuters Health) – The results of a randomized trial indicate that sequential and alternating chemotherapy with radiotherapy provide similar survival and larynx preservation in patients with…
By Anthony J. Brown, MD NEW YORK (Reuters Health) – The results of a small study suggest that occipital nerve stimulation is a safe treatment for intractable chronic…
NEW YORK (Reuters Health) – The addition of cetuximab to a fluoropyrimideine-based chemotherapy regimen reduces progression-free survival and worsens quality of life in patients with metastatic colorectal cancer,…
NEW YORK (Reuters Health) – Based on preliminary results in two patients with severe rheumatoid arthritis, intraarticular delivery of a gene encoding a cytokine blocker substantially reduces joint…
